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The Tax proteins of the oncovirinae viruses are
phosphorylated transcriptional activators that exhibit
oncogenic potential. The role of phosphorylation in their
functional activities remains unknown. As a model for
the Human T-cell leukemia virus type I (HTLV-I),
Bovine Leukemia Virus (BLV) permits the characteriza-
tion of viral replication and leukemogenesis in vivo.
Here, we show that the BLV Tax protein is phosphory-
lated on serine residues 106 and 293 both in insect and in
mammalian cells. These sites can also be eciently
phosphorylated by the cdc2 and MAP kinases in vitro.
Mutation of these residues does not aect the capacity of
the Tax protein to function as a transactivator. Indeed,
the Tax proteins mutated at one or both serines increase
LTR-directed viral transcription at levels similar to those
obtained with wild-type Tax in cell culture. Moreover,
inhibition of Tax phosphorylation by W7, a calmodulin
antagonist, does not alter its transactivation activity.
Thus, phosphorylation on serines 106 and 293 is not
required for transactivation by Tax. However, simulta-
neous substitution of both serines into alanine residues
destroys the capacity of Tax to cooperate with the Ha-
ras oncogene to transform primary rat embryo fibro-
blasts and induce tumors in nude mice. When the serines
were replaced with aspartic acid residues, the oncogenic
potential of Tax was maintained indicating that the
negative charge rather than the phosphate group itself
was required for Tax oncogenicity. Finally, to assess the
role of the serine residues in vivo, recombinant viruses
which express the Tax mutants were constructed and
injected into sheep. It appeared that the mutated
proviruses replicate at levels similar to the wild-type
virus in vivo. We conclude that Tax phosphorylation is
dispensable for transactivation and viral replication in
vivo but is required for its oncogenic potential in vitro.
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Introduction
Phosphorylation is an essential post-translational
modification in eucaryotic cells which governs a series
of mechanisms required for the regulation of transcrip-
tion (reviewed by Hunter and Karin, 1992). Three main
levels of regulation modulate transcription factor
activity. First, phosphorylation intervenes in transloca-
tion of the transcription factor between the cytosol and
the nucleus allowing the access to its target sequences.
Perhaps the best characterized example of this type of
regulation is provided by the Rel-related family of
transcription factors. These proteins are sequestered in
an inactive form in the cytoplasm and, in response to
an exogenous stimulus, are released and translocated to
the nucleus where they bind to specific target
sequences. This mechanism is illustrated by NF-kB
which is retained in an inactive complex in the
cytoplasm by the inhibitory protein IkB (Baeuerle
and Baltimore, 1988). Phosphorylation of the IkB
regulatory subunit triggers nuclear import of NF-kB.
The second level where phosphorylation modulates
transcription factor activity is DNA binding. One
example of negative regulation by phosphorylation is
the c-Myb protein. Phosphorylation of c-Myb on
serines 11/12 by casein kinase II results in a large
decrease in DNA binding activity (Lu¨scher et al.,
1990). In contrast, phosphorylation of the serum
response factor (SRF) by casein kinase II (CKII)
stimulates binding to the c-fos promoter (Manak and
Prywes, 1991; Janknecht et al., 1992; Marais et al.,
1992). Finally, a third mechanism by which phosphor-
ylation alters transcription is stimulation of transacti-
vation. In this case, phosphorylation can aect the
interaction of transactivation domains with the
transcriptional machinery. For example, phosphoryla-
tion of c-Jun on serines 63/73 in response to mitogenic
stimulation is responsible for a concomitant increase of
transactivation potential (Smeal et al., 1991). It thus
appears that phosphorylation can modulate transcrip-
tion by dierent mechanisms including protein
translocation, DNA binding activities and interactions
with the transcriptional machinery.
The Tax proteins of the oncovirinae viruses, a
subfamily which includes the Human T cell Leukemia
Virus (HTLV-I) and Bovine Leukemia Virus (BLV), have
been shown to be phosphorylated (Nyunoya et al., 1988;
Chen et al., 1989; Fontes et al, 1993). These proteins are
transactivators of viral transcription and modulate the
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expression of several cellular genes (reviewed by
Kettmann et al., 1994 and by Yoshida, 1996). One of
the mechanisms by which the Tax proteins activate
transcription is dimerisation of the CREB factor (Zhao
and Giam, 1992; Perini et al., 1995; Baranger et al., 1995;
Boros et al., 1995). Tax itself also acts as a dimer to
enhance the DNA binding activity of CREB (Tie et al.,
1996). Another mechanism of transactivation by Tax
involves the NF-kB family of transcription factors. By
facilitating the phosphorylation and degradation of IkB
and through interactions with IkBa or NFkB precursors,
Tax is able to increase the nuclear localization of NFkB
(reviewed by Yoshida, 1996). Finally, HTLV-I Tax
interacts directly with p67SRF to stimulate the expression
of the cellular proto-oncogene c-fos. Thus, Tax activates
transcription through three dierent enhancers: the
cyclic-AMP responsive element, the NF-kB-binding site
and the serum-responsive element. These pleiotropic
eects allow to activate transcription from various types
of promoters and modulate the expression of several
cellular genes (reviewed by Kettmann et al., 1994 and by
Yoshida, 1996). These functions of HTLV-I Tax appear
to be mediated by dierent domains of the protein (Smith
and Greene, 1990; Semmes and Jeang, 1992).
Besides their role in the regulation of transcription,
the Tax proteins also exhibit an oncogenic potential
(Nerenberg et al., 1987; Grassmann et al., 1989,
Pozzati et al., 1990; Tanaka et al., 1990; Willems et
al., 1990; Grossman et al., 1995; Akagi et al., 1997;
Matsumoto et al., 1997). Mice transgenic for the tax-I
gene develop either mesenchymal tumors or leukemia
depending on the promoter used for gene expression
(Nerenberg et al., 1987; Grossman et al., 1995). In
addition, the Tax protein is able to immortalize both
fibroblasts and T lymphocytes in culture in the context
of an Herpes saimiri virus-based vector (Grassmann et
al., 1989; Tanaka et al., 1990). The Tax proteins from
HTLV-I and BLV behave as immortalizing oncogenes
since they are able to cooperate with the Ha-ras
oncoprotein to fully transform primary rat embryo
fibroblasts (Pozzati et al., 1990; Willems et al., 1990;
Matsumoto et al., 1997). Both transactivation and
immortalizing functions of Tax can be dissociated by
mutations in specific regions of the protein. Indeed, the
transactivation of the LTR promoter is not required
for Tax to transform these cells (Willems et al., 1992;
Yamaoka et al., 1996). Finally, Tax is an essential gene
for viral replication since BLV recombinant viruses
that lack transactivation potential are not infectious in
vivo (Willems et al., 1993). It thus appears that the Tax
protein plays a key role in the oncogenic potential and
in the replication of the virus.
The role of Tax phosphorylation in transactivation
and immortalization activities is currently unknown.
The aim of this report is to help to gain insight into the
role of phosphorylation in immortalization and
transactivation by Tax.
Results
Two tryptic peptides from Tax are phosphorylated on
serine residues
Bovine leukemia virus is currently the best animal
model for HTLV-I because it allows the characteriza-
tion of the pathogenesis induced by mutant proviruses
after direct injection into sheep. It is thus possible to
analyse the infectious potential, the viral replication
and the leukemogenesis process in vivo. This is
particularly important because contradictory data
arise between in vitro and in vivo experiments. For
example, the deletion of the open reading frames
located between the env and tax genes does not alter
the behavior of the BLV and HTLV-II viruses in cell
culture but drastically decreases the proviral loads in
vivo (Willems et al., 1994; Green et al., 1995). Similar
data were obtained with the HTLV-II virus in rabbits
but this system does not yet allow to analyse the
leukemogenic process in vivo (Cockerell et al., 1996).
Since the BLV model provides a good system for the
understanding of HTLV-induced pathogenesis, we
chose to characterize the role of Tax phosphorylation
in this system.
To gain insight into the role of phosphorylation in
either transactivation or immortalization by BLV Tax,
we mapped the precise location of the phosphorylation
sites. To obtain sucient amounts of peptides for
direct sequencing, the BLV Tax protein was first
synthesized in insect SF9 cells using the baculovirus
expression system (according to Chen et al., 1989). SF9
cells expressing Tax were metabolically labeled with 32P
orthophosphate. After purification, 32P-labeled Tax
protein was acid-hydrolyzed and analysed by two-
dimensional thin-layer chromatography (TLC). Two
major and a few minor peptides were revealed after
autoradiography (Figure 1a). Since post-translational
modifications do not always occur eciently in insect
cells (Luckow and Summers, 1988), phosphorylation of
Tax was also analysed in mammalian cells. To this end,
Cos cells were transfected with the pSGTax plasmid,
an expression vector of the BLV tax gene (Willems et
al., 1990). Twenty-four hours post-transfection, the
cells were labeled overnight with 32P orthophosphate.
The Tax protein was then immunopurified using a
mixture of monoclonal antibodies, digested with
trypsin and analysed by TLC. Two labeled peptides
co-migrating with those obtained from the insect SF9
cells were observed (Figure 1a). It thus appears that the
Tax protein is phosphorylated on two major sites both
in insect and in mammalian cells. We next determined
the type of residue which was phosphorylated. There-
fore, the Tax protein was metabolically labeled with 32P
orthophosphate, purified as described above and acid-
hydrolyzed in chlorhydric acid at 1108C. After
lyophilization, the hydrolysates were migrated on a
TLC plate and autoradiographed. After standardiza-
tion with amino acids colored by ninhydrin, it
appeared that Tax was phosphorylated on serine
residues in both insect and mammalian expression
systems (Figure 1b).
Tax is phosphorylated on serines 106 and 293
Tryptic peptide maps of 32P-labeled Tax indicated that
two major peptides were phosphorylated in Cos and
SF9 cells. In spite of the presence of additional
peptides in the baculovirus-expressed Tax, this system
has the advantage of yielding high levels of protein that
then permit direct sequencing. The 32P-labeled peptides
were purified by high pressure liquid chromatography
(HPLC) and sequenced. Among six peptides, two of
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them (Ala98-Arg110 and Ile289-Lys296) yielded the
highest 32P counts. To determine whether these peptides
were targets for phosphorylation, serines 106 and 293
were substituted with alanines by site-directed muta-
genesis of the tax gene. Expression vectors encoding
wild-type Tax (pSGTax) and each of the two Ser?Ala
substitutions were transfected in Cos cells. The proteins
were metabolically labeled with 32P, immunopurified
and analysed by tryptic peptide mapping. The Ala106
substitution resulted in the disappearance of one
phosphopeptide (Figure 2a, pSGSer106) whereas the
Ala293 mutation abolished the other one (Figure 2a,
pSGSer293). The simultaneous substitution of serines
106 and 293 induced the disappearance of the two
phosphopeptides (Figure 2a, pSGSer106+293). The
lack of labeled peptide on the autoradiography could
be due to the instability of the mutant proteins or to
incomplete translation. Therefore, the wild-type and
the mutant Tax proteins were metabolically labeled
with of a mixture of 35S methionine and cysteine in Cos
cells. The Tax proteins were then immunoprecipitated
and migrated on a denaturing polyacrylamide gel
(Figure 2b). As a control for specificity, the cells were
also transfected with an empty pSG5 plasmid. None of
these mutations had any eect on the level of Tax
expression or on its stability. A similar experiment
performed on D17 (canine osteosarcoma) and primary
rat embryo fibroblasts (Ref) cells gave similar results
(data not shown).
In parallel to these experiments, a series of
mutations were introduced in other sites which were









































































Figure 1 (a) Phosphopeptide maps of the Tax protein expressed in SF9 or Cos cells. The Tax protein was expressed in Spodoptera
frugiperda (SF9) cells using the vAcTax baculovirus vector, labeled with 32P inorganic orthophosphate and purified by selective
precipitation. After tryptic digestion, the peptides were analysed by two-dimensional thin-layer chromatography. To analyse the
phosphorylation in Cos, the cells were transfected with the pSGTax eector plasmid and labeled with 32P inorganic orthophosphate.
The Tax protein was immunoprecipitated, digested with trypsin and analysed by two-dimensional TLC. (b) Two-dimensional TLC
of acid-hydrolyzed Tax protein expressed in SF9 or Cos cells. The Tax protein was expressed in SF9 and Cos cells and purified as
described in a. The Tax protein was next hydrolyzed in chlorhydric acid at 1108C for 1 h. The hydrolysates were spotted on a TLC
plate and analysed by two-dimensional electrophoresis. Standard amino acids (pSer, pThr and pTyr) were added to the hydrolysates
and colored with ninhydrin
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77, 104, 111, 116, 187 and 265). All these constructs
yielded phosphopeptide patterns similar to wild-type
Tax (data not shown).
We conclude therefore that the substitutions of both
serines 106 and 293 prevent the phosphorylation of
Tax on two major labeled peptides.
cdc2 and MAP kinases phosphorylate serines 106 and
293 in vitro
It appeared that serines 106 and 293 are the major
phosphorylated sites in BLV Tax in insect and
mammalian cells. In order to further support the
location of these sites, we determined the kinase which
could phosphorylate serines 106 and 293. Therefore,
the wild-type Tax protein was expressed in bacteria
using the pTIT vector under the control of the T7
RNA polymerase promoter (Studier et al., 1990). The
Tax protein was immunopurified and incubated with
dierent kinases in the presence of inorganic 32P-
orthophosphate. The reaction mixtures were then
analysed by TLC after tryptic digestion. It appeared
that the cdc2 kinase eciently phosphorylated two
peptides containing either serine 106 or serine 293
(Figure 3). These two peptides co-migrated with those
obtained from SF9 and Cos cells. In contrast, the
p44mpk mitogen-activated protein kinase (MAP) had a
marked preference for residue 293 but also phosphory-
lated serine 106 with a reduced eciency (Figure 3).
Two other kinases, PKC and PKA, were not able to
eciently phosphorylate the serine 293 residue but a
weak reaction was observed on site 106 (data not
shown). Finally, the casein kinase II was completely
inactive on both serine residues.
In conclusion, the cdc2 and MAP kinases are able
to phosphorylate serines 106 and 293 in an in vitro
reaction. It thus appears that these two serine residues
are targets for phosphorylation both in vitro and in
mammalian cells. These data further underline the
importance of these two sites for Tax phosphoryla-
tion.
Mutation of serines residues 106 and 293 does not alter
transactivation
Phosphorylation has been described to be essential for






































































































Figure 2 (a) Phosphopeptide maps of the mutated and wild-type Tax proteins in Cos cells. The plasmids encoding the wild-type
(pSGTax) and mutated (pSGSer106, pSGSer293 and pSGSer106+293) tax genes were expressed in Cos cells by transient
transfection and labeled with 32P orthophosphate. The tryptic phosphopeptide maps were then performed on the corresponding
immunopurified proteins. (b) Immunoprecipitation of the wild-type and mutated Tax proteins. Cos cells were transfected with
plasmids pSGTax, pSG5, pSGSer106, pSGSer293 and pSGSer106+293 and labeled with 35S methionine and cysteine. The Tax
proteins were then immunoprecipitated, migrated on a denaturing polyacrylamide gel and autoradiographied. The molecular weight
































Figure 3 In vitro phosphorylation of Tax by cdc2 and MAP
kinases (p44mpk). The wild-type Tax protein was expressed in
bacteria using the pTIT vector under the control of the T7 RNA
polymerase promoter. The Tax protein was next immunoprecipi-
tated with a mixture of monoclonal antibodies and incubated with
dierent kinases in the presence of inorganic [32P] orthopho-
sphate. After tryptic digestion, the reaction mixtures were
analysed by TLC
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transcription (Hunter and Karin, 1992). To address
the eect of the serine substitutions on transactivation
by Tax, expression vectors encoding wild-type Tax
(pSGTax) and each of the mutants (pSGSer106,
pSGSer293 and pSGSer106+293) were co-transfected
into Cos cells together with the pLTRCAT reporter.
This plasmid contains the BLV promoter cloned
upstream of the chloramphenicol acetyltransferase
gene (CAT). Forty-eight hours post-transfection, the
cells were harvested and the CAT activities were
determined from their lysates. The Tax mutants
yielded CAT activities similar to those obtained with
the wild-type protein (Figure 4). As a control for
background levels, transfection of the pSG5 plasmid
did not yield significant CAT activities. Dierent
amounts of eector and reporter plasmids used in
Cos, D17 or Ref cells gave similar results (data not
shown). It appeared from these transient transfection
experiments that phosphorylation at serines residues
106 and 293 is not required for transactivation by
Tax.
An inhibitor of Tax phosphorylation does not alter its
transactivation potential
Phosphorylation of Tax at serines 106 and 293 thus
appears dispensable for transcriptional activation. To
confirm these data, we developed another experimental
protocol based on the use of chemicals able to inhibit
phosphorylation of Tax. Therefore, Cos cells were co-
transfected with plasmid pSGTax to express the wild-
type Tax protein and the pLTRCAT reporter. The
transfected cells were then cultivated in the presence of
a series of chemicals including W7 (N-(6-aminohexyl)-
5-chloro-1-naphtalenesulfonamide), TFP (trifluopera-
zine) and H7 (1-(5-isoquinolinylsulfonyl)-3-methylpi-
perazine dihydrochloride). Twenty-four hours post-
transfection, they were metabolically labeled overnight
with either 32P inorganic phosphate or a mixture of 35S
methionine and cysteine. Then, the cells were harvested
and the Tax protein was immunoprecipitated from
their lysates (Figure 5). It appeared that, under the
experimental conditions used, the amounts of 35S-
labeled Tax protein were not altered after incubation
with the dierent chemicals (Figure 5a). In contrast,
the W7 calmodulin antagonist, but not TFP or H7,
strongly decreased the incorporation of 32P into Tax
(Figure 5b) indicating that W7 does not alter Tax
expression but modulates its phosphorylation. The
CAT activities were next determined from cells
cultivated in the presence or in the absence of that
chemical. It appeared that the incubation with the W7
calmodulin antagonist yielded CAT activities similar to
the wild-type levels obtained in the absence of any
chemical. Transfection of dierent amounts of pSGTax
eector and pLTRCAT reporter plasmids gave similar
results (data not shown). We conclude that it is
possible to aect Tax phosphorylation without
concomitant eect on its transactivation function.
These data further support our transient transfection
experiments using Tax mutants substituted on serines
106 and 293.
Phosphorylation at both serines 106 and 293 is required
for Tax-induced transformation in vitro
The BLV Tax transactivator protein is also known to
be involved in cell transformation (Willems et al.,
1990). Indeed, Tax cooperates with Ha-ras to trans-
form primary rat embryo fibroblasts (Ref) that are
then capable of inducing tumors in thymusless nude
mice. To investigate the role of phosphorylation at
serines 106 and 293 in the oncogenic potential of Tax,
vectors expressing the mutants (pSGSer106 or
pSGSer293) were co-transfected with the Ha-ras
oncogene in Ref cells. Three days post-transfection,
the cells were directly injected into nude mice.
Mutation of one of the two phosphorylated serines
(either Ser106 or Ser293) slightly increased the
oncogenic potential of wild-type Tax (Figure 6,
compare pSGSer106 and pSGSer293 with pSGTax).
The mean volume of the tumors at one month post-
injection increased by 50 – 70% where 100 was wild-
type. In contrast, simultaneous mutation of both
serines into alanine residues completely destroyed the
oncogenic potential of Tax (Figure 6,
pSGSer106+293). The mean tumor volume after one
month was similar to the background levels obtained
with Ref cells cotransfected with the Ha-ras oncogene
and the control plasmid pSG5. Although it was unable
to cooperate with Ha-ras, the Ser106+293 mutant was
expressed as eciently as the wild-type Tax (Figure 2b
and data not shown). We conclude that single
substitution of the phosphorylation sites does not
aect primary cell transformation whereas their
Figure 4 Transactivation by the wild-type and mutated tax
genes. Five micrograms of the dierent eector plasmids
(pSGTax, pSGSer106, pSGSer293, pSGSer106+293 or the
pSG5 control) and 2 mg of pLTRCAT reporter were transfected
into D17 cells by the calcium phosphate co-precipitation
procedure. CAT activities were determined 48 h post-transfec-
tion. The 14C-acetylated chloramphenicol forms were counted at
regular intervals to determine the linear range of the reaction.
Mean values of three independent measurements performed at 1 h
are represented
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concomitant mutation completely destroys Tax onco-
genic potential.
To further gain insight into the role of phosphoryla-
tion into the oncogenic potential of Tax, the serines
106 and 293 were substituted with aspartic acid.
Indeed, it could be that the negative charge rather
than the phosphate group itself is required for
transformation. Therefore, both serine residues 106
and 293 were mutated in aspartic acid and inserted in
the pSG5 vector. The resulting plasmid, called
pSGTax2xAsp, was co-transfected into Ref cells
together with the pSV2neoEJ vector. The transfected
cells were next analysed for their ability to induce
tumors after injection into nude mice. It appeared that
the Tax2xAsp mutant very eciently induced tumors
with increased growth potential compared to the wild-
type levels (mean tumor volume of 4553 mm3 at 1
month versus 1639 for wild-type). We conclude that the
substitution of serines 106 and 293 with aspartic acid
maintains Tax oncogenic potential in primary cultures.
Mutation of serines 106 and 293 does not alter viral
replication in vivo
To analyse the eect of the serine mutations on viral
replication, we used provirus 344 proven to be infectious
and pathogenic in vivo (Willems et al., 1994) to construct
three recombinant proviruses (pBLVTax106,
pBLVTax293 and pBLVTax106+293) harboring the
tax mutants. The dierent proviruses were first analysed
in cell culture in transient co-transfection assays together
with the pLTRCAT reporter plasmid. It appeared that
the substitutions on serines 106 and 293 yielded CAT
activities similar to the wild-type levels (Figure 7a). Since
the wild-type and recombinant proviruses yielded similar
CAT activities, we conclude that phosphorylation at
serines 106 and 293 is not required for transactivation by
Figure 5 The W7 calmodulin antagonist inhibits phosphorylation of Tax but its transactivation potential. Cos cells were
transfected with plasmid pSGTax and the pLTRCAT reporter. The transfected cells were next cultivated in the presence of
chemicals: W7, trifluoperazine (TFP) or H7. Twenty-four hours post-transfection, half of the cells were metabolically labeled
overnight with either a mixture of 35S methionine and cysteine (a) or 32P inorganic phosphate (b) and the Tax protein was
immunoprecipitated from their lysates. The CAT activities were determined from the other half of the transfected cells cultivated in
the presence or in the absence of chemical (c). The background levels obtained after transfection of the pSG5 plasmid represented
































































Figure 6 Oncogenic potential of the wild-type and mutated Tax
proteins. Primary rat embryo fibroblasts (Ref) were transfected
with plasmids containing the wild-type (pSGTax) or the mutated
tax genes (pSGSer106, pSGSer293, pSGSer106+293,
pSGTax2xAsp) and the empty vector (pSG5) were co-transfected
together with the pSV2neoEJ construct that encodes the Ha-ras
oncogene. Forty-eight hours post-transfection, the cells were
collected, washed with PBS and injected subcutaneously into
thymusless nude mice. A total of four mice in two independent
experiments were injected for each tax gene. The tumor volume
was calculated by the ellipsoid formula: 4/3 P a b2 where a and b
are respectively the length and the width of the tumor. The mean
values among all the tumor volumes are indicated in mm3
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Tax. These results confirm the CAT activities obtained
after transfection of the tax genes cloned into the pSG5
expression vector (see Figure 4).
The behavior of the mutated proviruses was next
studied in vivo. A series of eight sheep were injected
intradermally with wild-type (plasmid pBLVIX which
contains provirus 344) or recombinant (pBLVTax106,
pBLVTax293 and pBLVTax106+293) viruses. All
three recombinant proviruses were infectious as
demonstrated by serology and PCR (data not shown
and Figure 7b). The phosphorylation of serines 106
and 293 is thus not required for in vivo viral infectivity.
To assess the eciency of viral replication, the proviral
loads were measured by semi-quantitative polymerase
chain reaction (PCR) (Figure 7b). Cell lysates were
prepared from peripheral blood collected by jugular
venipuncture at three months post-infection. The tax
gene sequences were amplified from these lysates by 22
cycles of PCR. Under these conditions, amplification of
viral sequences is semiquantitative in comparison with
serial dilutions of the positive control (sheep M11 at 1
year post-infection 16, 106, 1006). The amount of
viral sequences produced by the recombinant viruses
were similar to wild-type virus levels (compare sheep
M258, M270, M296, M104 and M480 to M11, M292
and M293). This experiment was repeated at 6 months
post-infection and gave similar results (data not
shown). As a control, the PCR-amplified tax
sequences were directly sequenced to verify that the
specific mutations were still present in these in vivo
propagated viruses (data not shown). This demon-
strated that the viruses harboring the mutations were
not wild-type revertants. Since the proviral loads were
similar in all animals, it appears that the substitution
of serines 106 and 293 does not impair viral
propagation in vivo.
Discussion
We have previously shown that it is possible to
dissociate the transactivation and immortalization
functions of Tax by mutations in the zinc finger
structure (Willems et al., 1992). These mutants have
indeed lost their capacity to activate viral expression
directed by the LTR but are capable to immortalize
primary cells. In this report, we have characterized
mutations that destroy Tax oncogenic potential with-
out concomitant loss of transactivation function. We
have indeed demonstrated that two residues of the Tax
transactivator protein, serines 106 and 293, are
phosphorylated in vitro, in insect cells and in
mammalian cells. When these serines are mutated into
alanines or into aspartic acid residues, the Tax protein
still activates LTR-directed gene transcription but does
not transform primary cells. There is a bunch of
literature concerning the role of phosphorylation in the
regulation of transcription. Much less data are
available concerning the interplay between phosphor-
ylation, transactivation and oncogenic potential.
Inhibition of phosphorylation has been shown to
enhance the transformation activity of oncogenic
proteins. For example, alteration of a cyclic AMP-
dependent protein kinase phosphorylation site in the c-
Fos protein augments its transforming potential
(Tratner et al., 1992). Similarly, the phosphorylation
sites in the amino-terminal domain of c-Myc modulate
its oncogenic potential (Henricksson et al., 1993).
Indeed, cells expressing a chicken c-Myc harboring a
mutation of Thr61/Ser65 have an increased growth
potential in soft agar compared to wild-type transfec-
tants. It thus appears that c-Myc function is negatively
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Figure 7 Transactivation potential and replication of wild-type
and mutated proviruses. (a) Transactivation by the wild-type and
mutated tax genes. Five micrograms of the dierent eector
plasmids (pBLVHind that harbors the wild type 344 provirus,
pBLVTax106, pBLVTax293 and pBLVTax106+293) and 2 mg of
pLTRCAT reporter were transfected into D17 cells by the
calcium phosphate co-precipitation procedure. As a control,
plasmid pGem was analysed in parallel. CAT activities were
determined 48 h post-transfection. Mean values of three
independent experiments are represented as 14C-acetylated
chloramphenicol at 1 h of incubation. (b) In vivo replication of
the proviruses mutated in the tax gene. Plasmid DNA containing
the dierent mutant viruses (pBLVSer106, pBLVSer293,
pBLVSer106+293) and the corresponding wild-type provirus
(pBLVIX) were injected into sheep. At 3 months post-injection,
the proviral loads were estimated by semi-quantitative PCR using
oligonucleotides flanking the tax gene. After PCR, the samples
were analysed by Southern blot hybridization using a tax probe.
As a control for semi–quantitative amplification, serial dilutions
of the wild-type provirus were amplified in parallel using a blood
lysate from sheep M11 1 year post-infection. MW are the
molecular weight standards (1 kb ladder, Promega). This
experiment was performed at least in triplicate
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regulated by phosphorylation. In contrast, the onco-
genic potential of c-Jun requires phosphorylation on
serines 63 and 73 (Smeal et al., 1991). In this case,
however, the transactivation function of c-Jun in
cooperation with Ha-ras is lost. To our knowledge,
the sole example where inhibition of phosphorylation
impedes transformation without aecting transcrip-
tional activation is provided by the E7 protein of
human papillomavirus type 16 (Firzla et al., 1991).
Serine to alanine mutations that changed the casein
kinase II phosphorylation site drastically reduced the
ability of E7 to co-transform primary cells with ras
whereas its transactivation capability of the E2
promoter remained unaected. We provide here an
example where the transforming potential of a retro-
viral transactivator requires phosphorylation of two
serine residues independently of its transactivation
function. The analogies between the Tax and E7
proteins is even strengthen by the fact that the
negative charge provided by an aspartic acid residue
restores the oncogenic potential of both transactiva-
tors. This observation could indicate that phosphoryla-
tion by itself is not required for transformation which
would then only require a net negative charge at these
sites. Alternatively, the substitution with negatively
charged residues would mimic a phosphorylated serine
and allow transformation of Ref cells. In this case, the
phosphorylation of Tax could be a pathway which
could allow the modulation of its oncogenic potential.
Therefore, it would be of particular interest to analyse
the pathogenicity induced by a BLV provirus
harboring aspartic acid residues at positions 106 and
293. Such a mutant could be particularly leukemogenic
in the sheep animal model.
It should be recalled here that our transformation
assay is based on the cooperation of BLV Tax with the
Ha-ras oncogene in rat embryo fibroblasts. This
transformation assay, which was extensively used in
the past in dierent systems, has recently been shown
to present some limits. Indeed, a HTLV Tax mutant
(M703), which was deficient in the CArG transactiva-
tion pathway, was unable to transform Ref cells but
eciently immortalized T lymphocytes in culture
(Akagi et al., 1997; Matsumoto et al., 1997).
However, the immortalized cultures exhibited an
aberrant phenotype of CD8+ instead of CD4+ cells.
There is thus no strict correlation between the Ref
transformation assay and the immortalization of T
lymphocytes in culture. Similarly, it is possible that the
defect of the BLV Tax phosphorylation mutant in the
Ref transformation assay reflects cell target specificity
but not oncogenicity in vivo. Of note, in contrast to
HTLV Tax, both the wild-type and mutant BLV Tax
proteins were unable to activate the CArG pathway.
In insect cells, the BLV and HTLV-I Tax
transactivators have been shown to be phosphorylated
(Nyunoya et al., 1988; Chen et al., 1989). This post-
translational modification appears to be conserved
through the evolution since HTLV-I Tax is also
phosphorylated in human lymphocytic cell lines
(Fontes et al., 1993). We have shown in this report
that BLV Tax is also phosphorylated in insect and in
mammalian cells, and that serines 106 and 293 appear
to be the only residues which are phosphorylated in an
in vitro kinase reaction. The conservation of this post-
translational modification allowed us to map the
phosphorylated sites within the Tax protein. The
identification of the phosphorylation sites was based
on the incorporation of 32P in the tryptic peptides
obtained from the Tax protein expressed in SF9 cells.
Mutation of these two residues abrogated the
incorporation of 32P within the tryptic peptides as
shown by thin layer chromatography of Tax expressed
in mammalian cells. To further support these data, a
series of mutations were introduced in other sites that
were target candidates for phosphorylation. We
mutated the tax gene at serines 77, 111 and 265
because the peptides corresponding to these residues
gave minor signals after the HPLC column. A serine to
alanine mutation was also introduced at residue 104
because tryptic digestion did not dierentiate between
serines 104 and 106. In addition, since tyrosine
phosphorylation is very inecient in insect cells, the
two tyrosines of Tax (residues 116 and 187) were also
substituted with alanine. All these constructs yielded
phosphopeptide patterns similar to wild-type (data not
shown). It should be mentioned here that the mutation
of serine 106 into alanine within Tax also modifies the
Rex protein which is translated from an alternative
open reading frame on the same messenger RNA.
However, this phenylalanine to leucine substitution
does not seem to alter Rex function since recombinant
viruses harboring the mutation exhibit a wild-type
behavior in vivo.
Phosphorylation of Tax does not alter its transacti-
vation capacity in cell culture. This is supported not
only by transient transfection experiments of mutant
tax genes but also by the use of a calmodulin
antagonist (W7). Indeed, this chemical inhibits Tax
phosphorylation but does not alter transactivation of
the LTR promoter. In contrast, trifluoperazine,
another calmodulin antagonist having another spec-
trum of inhibition does not alter Tax phosphorylation
and its transactivation function in cell culture.
Similarly, inhibition of the protein kinase C pathway
with H7 does not modulate Tax phosphorylation. We
can thus speculate that a calmodulin-dependent path-
way is required for ecient phosphorylation of Tax
but is dispensable for transactivation. However, we
should mention here that W7 also inhibits PKC and
that H7 interferes with the cAMP and cGMP pathways
(Hidaka et al., 1981). Therefore, we should be cautious
about the interpretation of data based on the use of
chemicals that are not entirely specific. In any case, by
using the W7 calmodulin antagonist, it is possible to
abrogate Tax phosphorylation without aecting its
transactivation function. This observation further
supports our data based on the use of Tax mutants
substituted on serines 106 and 293.
Phosphorylation has been shown to modulate the
nuclear localization of a transcription factor (Hunter
and Karin, 1992). Likewise, the substitution of serines
106 and 293 could modify the subcellular localization
of Tax. Since the mutants are competent for
transcriptional activation, one could assume that the
nuclear localization of Tax is not altered by the
mutations in the phosphorylation sites. Indirect
immunofluorescence staining did indeed not unravel
significant dierences among the wild-type and mutant
Tax proteins (data not shown). To strengthen these
observations, the wild-type and mutated Tax proteins
were also fused to the green fluorescent protein (GFP)
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that allows direct examination under the fluorescence
microscope without prior fixation. All the GFP-Tax
proteins were present mainly in the nucleus but also to
a lesser extent in the cytoplasm of Cos, Ref and Hela
cells (data not shown). It thus appears that the
subcellular localization of Tax is not modified by the
mutations in the phosphorylation sites. However, it is
possible that its association with cellular factors is
altered leading to a defect in oncogenicity. Further
colocalization studies by confocal microscopy are
currently under way.
As a model for the human T-cell leukemia virus type
I, the infection of sheep by BLV provides a model to
analyse viral infectivity, replication and leukemogenesis
in vivo. We have shown here that proviruses
recombinant for the Tax phosphorylation sites exhibit
wild-type behavior when injected into sheep. The
proviral loads within the infected sheep are indeed
similar to the wild-type levels at three and six months
post-injection. This observation provides a strong
argument for the absence of phosphorylation require-
ments to ensure transactivation. Indeed, we have
previously shown that the infectious potential of BLV
proviruses requires a functional Tax protein (Willems
et al., 1993). In fact, a provirus (clone 395) exhibits a
tenfold reduction in transactivation activity due to the
presence of two mutations in the tax gene (two
glutamine codons are substituted with lysine resi-
dues). This virus is not infectious in vivo when injected
into sheep. In contrast, when a functional tax gene is
provided, the recombinant provirus becomes infectious
and replicates at wild-type levels in vivo (Willems et al.,
1993). Since the proviruses recombinant for the Tax
phosphorylation sites 106 and 293 propagate at wild-
type levels in vivo, it appears that essential genes such
as Tax and Rex are not aected by these mutations.
Altogether, these data demonstrate that LTR-directed
transactivation and viral replication in vivo do not
require the phosphorylation of Tax on serines 106 and
293. In addition, the oncogenic potential of Tax, as
measured by a transformation assay of primary Ref
cells in cooperation with Ha-ras, is dispensable for
infectivity and propagation in vivo. It thus appears that
the in vitro oncogenic potential of Tax is not required
for viral persistence in sheep. Whether Tax phosphor-
ylation is required for the induction of leukemia or for
cell target specificity is currently unknown. The
availability of proviruses harboring a tax gene that
lacks oncogenic potential as measured by an in vitro
cell transformation assay provides a very convenient
tool to analyse its role in leukemogenesis in vivo.
Materials and methods
Phosphopeptide maps of the Tax protein
The Tax protein was expressed in Spodoptera frugiperda
(SF9) cells using the vAcTax baculovirus vector as
described by Chen et al. (1989). SF9 cells were collected
48 h after infection and incubated for 1 h in phosphate-free
TC100 medium supplemented with 5% dialyzed foetal calf
serum (FCS, Gibco), followed by incubation with 300 mCi/
ml of 32P-labeled inorganic orthophosphate (Amersham)
for 4 h. The cells were then washed three times in
phosphate-buered saline (PBS) containing 20 mg/ml
sodium orthovanadate. After centrifugation, the cells were
lysed in a buer containing 20 mM sodium phosphate
pH 7.6, 0.5 M NaCl, 0.5% Tween 20, 20 mg/ml sodium
orthovanadate, 1 mM PMSF and 6 M guanidinium chlor-
hydrate. The concentration in guanidinium chlorhydrate
was progressively reduced to 1.5 M allowing the selective
precipitation of Tax. The Tax protein was recovered by
centrifugation for 1 h at 34 000 g, resuspended in 50 mM
ammonium bicarbonate and digested with 1 mg/ml trypsin
(Promega) for 20 h at 378C. The reaction was then
incubated for 2 h in the presence of additional trypsin
(0.2 mg/ml) to ensure complete digestion of Tax. After
lyophilization, the protein pellet was resuspended in 20 ml
TLC buer pH 1.9 (formic acid 2%-acetic acid 7.8%).
After a brief centrifugation in a microfuge, the supernatant
was spotted on a TLC plate (Merck). The sample was then
electrophoresed for 40 min at 1.5 kV in TLC buer pH 1.9
(apparatus type Hunter Thin Layer Electrophoresis HTLE-
7000, C.B.S.). After drying, the TLC plate was chromato-
graphied in the second dimension in a buer containing
n-butanol 37.5%/pyridine 25%/acetic acid 7.5% during
15 h and autoradiographied.
To analyse the phosphorylation in mammalian cells,
300 000 Cos cells were transfected with 5 mg of eector
plasmids pSGTax (Willems et al., 1990), pSGSer106,
pSGSer293 and pSGSer106+293 using the calcium phos-
phate procedure (Promega) and cultivated for 20 h at 378C in
a 5%/95% CO2/air atmosphere in minimal essential medium
(MEM, Gibco) supplemented with 10% FCS, sodium
pyruvate 1 mM, L-glutamine 2 mM, penicillin (100 U/ml)
and streptomycin (100 mg/ml). The medium was replaced by
MEM medium without phosphate supplemented with 5%
dialyzed FCS and cultivated for 2 h. After washing, the cells
were incubated overnight in the same medium containing
1 mCi/ml 32P-labeled inorganic orthophosphate. After three
washes with PBS, the cells were lysed in 1 ml NET buer
(50 mM Tris pH 8.0, 150 mM NaCl, 0.5% Nonidet P-40,
EDTA 5 mM, SDS 0.5%) containing 20 mg/ml sodium
orthovanadate and 1 mM PMSF (phenylmethylsulfonyl
fluoride). The Tax protein was immunoprecipitated with
two monoclonal antibodies (5A5 and 6A7), a polyclonal
serum directed towards mouse immunoglobulins and protein
A CL-4B (Pharmacia). After 20 h incubation at 48C, the
immune complexes were washed three times in RIPA-I buer
(150 mM NaCl, 50 mM Tris pH 7.2, 1% Triton X100, 1%
sodium deoxycholate) and two times in RIPA-II (50 mM
NaCl, 50 mM Tris pH 7.2). The immunopurified Tax protein
was then resuspended in 50 mM ammonium bicarbonate,
digested with trypsin and spotted on a TLC plate. The
sample was then electrophoresed, chromatographied in two
dimensions and autoradiographied.
Two-dimensional thin-layer chromatography of acid hydrolyzed
Tax protein
The purified Tax protein was resuspended in 1 ml
chlorhydric acid 5.7 M and incubated at 1108C during 1 h.
After lyophilization, the hydrolysates were resuspended in
10 ml of TLC buer pH 1.9 containing standard amino acids
and spotted on a TLC plate. The amino acids were
electrophoresed at 1.5 kV during 20 min in TLC buer
pH 1.9. After drying, the samples were migrated in the
second dimension at 1.3 kV in TLC buer pH 3.5 (5% acid
acetic acid, 0.5% pyridine). Before autoradiography,
standard amino acids were visualized with 0.25% ninhydrin
(Sigma) in acetone after incubation at 658C during 15 min.
Identification of the phosphorylation sites
The Tax protein was expressed in SF9 cells, labeled with
32P orthophosphate, purified and digested with trypsin. The
peptides were then resuspended in 200 ml trifluoroacetic
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acid (TFA) and loaded on an inverse phase HPLC column
type 4. The samples were migrated in a gradient formed by
two solvents a (0.1% TFA) and b (0.1% TFA in 70%
acetonitrile) at a flow rate of 1 ml/min. After the HPLC,
the samples were resuspended in TLC buer pH 1.9 and
one tenth of them was migrated on a TLC plate at 1.5 kV
during 40 min in the HTLE-7000 apparatus. After
autoradiography, the fractions that contained labeled
peptides were lyophilized, resuspended in 100% TFA and
sequenced by the Edman degradation procedure using the
Applied Biosystem 477A and 120A apparatus.
Site-directed mutagenesis of the phosphorylation sites
The serine codons at positions 106 and 293 were mutated by
site-directed mutagenesis of the pGemLOR plasmid that
contains the tax gene cloned into pGem7 (Willems et al.,
1990). Therefore, primers containing the appropriate
mutation were used: Ser106 5'-CCGGTTTCACTTGCC-
CCCTTC-3', Ser293 5'-GGACTTGATGCCCCCTTAA-
AA-3' and their corresponding complementary oligonucleo-
tides (Ser106c and Ser293c). A first round of PCR allowed
the amplification of each half of the tax gene using the SP6
and T7 primers located in the pGem7 plasmid. After
agarose gel electrophoresis, the DNA fragments were
purified using the Sephaglas kit (Pharmacia). A second
round of PCR using the SP6 and T7 oligonucleotides
allowed to reconstitute the tax gene harboring the selected
mutation. The mutated genes were introduced in the pSG5
plasmid (at the XhoI and BamHI sites) and sequenced to
ensure for the presence of the substitution and the lack of
Taq DNA polymerase errors. The resulting plasmids
(pSGSer106 and pSGSer293) were used to construct the
hybrid vector pSGSer106+293 using the EcoRI site located
within the tax gene. A similar strategy was used to construct
plasmid pSGTax2xAsp in which the serines 106 and 293
were substituted with aspartic acid instead of alanines.
To construct the proviruses mutated in the tax gene, the
infectious and tumorigenic provirus 344 was used (Willems
et al., 1994). Therefore, the 3' proviral end of plasmid
pBLVSal (that corresponds to pBLV344 with a SalI-SalI
deletion of the 3' cellular flanking sequences) was site-
directed mutagenized by a two step PCR-based strategy. To
mutagenize codon 106, the primers used were X31 (5'-
TGGAAAGAACTAACGCTG-3') with Ser106c and Ser106
with Ser293Bc (5'-TTTTAAGGGTGCATCAAGTCT-3') to
amplify the first and the second half of the tax gene,
respectively. The tax gene was reconstituted by a second
round of PCR using the X31 and Ser293Bc oligonucleotides.
To mutate codon 293, the primers used were Ser106 with
Ser293Bc and Ser293B (complementary to Ser293Bc) with
SP6 to amplify the first and the second half of the tax gene,
respectively. The tax gene was reconstituted by a second
round of PCR using the Ser106 and SP6 oligonucleotides.
The mutated proviral sequences were cloned into plasmids
pGem7 or pCRII (In Vitrogen) to generate pGemTaxB106
and pCRTax293. The mutated genes were sequenced to
ensure for the presence of the substitution and the lack of
Taq DNA polymerase errors. The resulting plasmids
(pGemTaxB106 and pCRTax293) were used to reconstitute
the provirus using the XbaI and SalI sites to generate
pBLVTax106 and pBLVTax293. The provirus
pBLVTax106+293 that contains a substitution at the level
of both serines 106 and 293 was constructed using the
EcoRI site located within the tax gene.
Immunoprecipitation of the wild-type and mutated Tax proteins
The pSGTax, pSG5, pSGSer106, pSGSer293 and
pSGSer106+293 plasmids were transfected into Cos cells
by the calcium phosphate procedure. Twenty hours post-
transfection the cells were cultivated for 2 h in the presence
of MEM medium without methionine and cysteine
containing 5% dialyzed FCS. The cells were labeled
overnight with 100 mCi/ml of a mixture of 35S-methionine
and cysteine (Translabel, ICN). The Tax proteins were then
immunoprecipitated, migrated on a 12.5% polyacrylamide-
SDS (sodium dodecylsulfate) gel and autoradiographied.
The molecular weight markers on Figure 2 (MW) are
30 kDa (bottom), 44 kDa and 69 kDa (top) (Amersham).
In vitro kinase assays
The Tax protein was expressed in HMS174 bacteria
essentially as described by Studier et al. (1990). In brief,
the pTITTax plasmid (Willems et al., 1992) that contains
the tax gene cloned downstream of the T7 RNA
polymerase promoter was introduced into HMS174
bacteria and cultivated in liquid M9 minimal essential
medium containing 50 mg/ml ampicillin. Exponentially
growing cultures of the transformed bacteria were then
infected with bacteriophage CE6 which encodes the T7
RNA polymerase (at a multiplicity of infection of 10).
After 2 h, the bacteria were lysed and the Tax protein was
immunopurified as described above. After purification, the
Tax protein was incubated in the presence of dierent
commercial kinases: cdc2 and MAP kinases (UBI), PKC
and CKII (Boehringer) and PKA (Promega). Kinase
reactions were performed as described by the manufac-
turers in the presence of 2 mCi of [32Pg]ATP and 10 mM cold
ATP. The Tax protein was then digested with trypsin and
analysed by two-dimensional TLC.
CAT assays
Five micrograms of the dierent eector plasmids and 2 mg
of pLTRCAT reporter were transfected into 300 000 Cos,
D17 or Ref cells by the calcium phosphate co-precipitation
procedure. The pLTRCAT plasmid contains the BLV LTR
cloned upstream of the chloramphenicol acetyltransferase
gene. Forty-eight hours post-transfection, CAT activities
were determined from the cell lysates. The 14C-acetylated
chloramphenicol that migrated into the Econofluor (NEN)
phase was counted at regular intervals. At 1 h of
incubation, the reaction was still in the linear range. The
data represent the mean values of at least three
independent experiments (the standard deviations being
less than 10%).
To inhibit Tax phosphorylation a series of chemicals from
Sigma were added to the culture medium: an inhibitor of
protein kinase C, H7 (1-(5-isoquinolinylsulfonyl)-3-methylpi-
perazine dihydrochloride at a concentration of 10 mM) and
two calmodulin antagonists, W7 (N-(6-aminohexyl)-5-chloro-
1-naphtalenesulfonamide at concentrations of 2.5 or 25 mM)
and TFP (trifluoperazine at concentrations of 1 or 10 mM).
In vivo replication of the proviruses mutated in the tax gene
One hundred mg of plasmid DNA containing the wild-type
provirus (pBLVIX) and the dierent mutants
(pBLVTax106, pBLVTax293, pBLVTax106+293) were
injected into sheep as previously described (Willems et
al., 1993). In brief, 100 mg of proviral DNA were mixed
with 200 ml DOTAP (N-(1-(2,3 -dioleoloxyl) propyl)-
N,N,N, -trimethyl- ammoniummethylsulfate, Boehringer)
in 1 ml HBS (HEPES 20 mM, NaCl 150 mM, pH 7.4) and
injected intradermally in the back of BLV-free sheep. The
animals were maintained under controlled conditions at the
National Institute for Veterinary Research (Uccle, Bel-
gium). Their serum was collected at regular intervals and
analysed for the presence of BLVgp51 specific antibodies
by the ELISA procedure (Portetelle et al., 1989). At 3
months post-injection, the proviral loads were estimated as
previously described (Willems et al., 1994). In brief, blood
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samples (500 ml aliquots) were mixed with an equal volume
of lysis buer (0.32 M sucrose, 10 mM Tris-HCl pH 7.5,
5 mM MgCl2, 1% Triton X-100). After 20 s centrifugation,
the pellets were resuspended in 1 ml lysis buer. This step
was repeated twice. The samples were then resuspended in
200 ml PCR buer (50 mM KCl, 2.5 mM MgCl2, 10 mM
Tris-HCl pH 9, 0.1% Triton X-100) and incubated with
1 ml proteinase K (5 mg/ml) for 1 h at 508C. The digestions
were stopped by boiling the sample for 5 min. Ten ml
aliquots were amplified by PCR in the presence of 0.2 mM
each dNTPs, 200 ng primers and 1 U of Taq DNA
polymerase (Boehringer). Two oligonucleotides were used:
PCRTD (5'-AACGACAAAATTATTTCTTGTC-3') and
PCRTC (5'-CCTGCATGATCTTTCATACAAAT-3'). The
reaction mixtures were overlaid with two drops of mineral
oil, denatured for 5 min. at 948C and amplified by 22 cycles
(30 s at 948C, 30 s at 578C and 1 min at 748C). After PCR,
the samples were analysed by Southern blot hybridization
using a tax probe. As a control for semi-quantitative
amplification, serial dilutions of the wild-type provirus
were amplified in parallel using a blood lysate from sheep
M11 1 year post-infection. MW are the molecular weight
standards (1 kb ladder, Promega). These experiments were
performed in triplicate at 3 and 6 months after
seroconversion.
Transformation of primary rat embryo fibroblasts
Primary rat embryo fibroblasts (Ref) were prepared from
F344 rats at day 14 of pregnancy (IFFA CREDO) and
cultivated for 2 days in MEM medium supplemented with
10% FCS, sodium pyruvate 1 mM, L-glutamine 2 mM,
penicillin (100 U/ml) and streptomycin (100 mg/ml). The
plasmids (5 mg) containing the wild-type (pSGTax) or the
mutated tax genes (pSGSer106, pSGSer293,
pSGSer106+293 and pSGTax2xAsp) and the empty
vector (pSG5) were co-transfected together with the
pSV2neoEJ construct that encodes the Ha-ras oncogene
into 26106 Ref cells. As a control for equal expression of
the Tax protein, an immunoprecipitation and a CAT assay
was performed in parallel (data not shown). Forty-eight
hours post-transfection, the cells were collected, washed
with PBS and injected subcutaneously into thymusless
nude mice. A total of four mice in two independent
experiments were injected for each tax gene construct. The
tumor volume was calculated by the ellipsoid formula: 4/3
P a b2 where a and b are respectively the length and the
width of the tumor. The mean values between all the tumor
volumes are indicated in mm3.
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